{"ticker": {"uuid": "c54d7c9b-29e6-4f69-80f6-14054a23e3ee", "symbol": "ASND", "name": "Ascendis Pharma AS", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Ascendis Pharma Reports Second Quarter 2026 Financial Results", "summary": "Ascendis Pharma \u2013 Q2 2026 product revenue of \u20ac315 million (+105% Y/Y), comprising \u20ac252 million for YORVIPATH\u00ae, \u20ac55 million for SKYTROFA\u00ae, and \u20ac8 million for YUVIWEL\u00ae \u2013 Through July 31, more than 220 unique YUVIWEL patient enrollments in the U.S. \u2013 Substantial pipeline updates: presented long-term Phase 2 & 3 YORVIPATH data, shared Week 78 COACH Trial data, and completed target enrollment for pivotal infant reACHin Trial \u2013 Settled all convertible notes and Ascendis added to multiple Russell U.S. Indexes \u2013 Conference call today at 8:00 am ET COPENHAGEN, Denmark, Aug. 13, 2026 (GLOBE NEWSWIRE) --", "url": "https://finance.yahoo.com/healthcare/articles/ascendis-pharma-reports-second-quarter-113000247.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-13T11:30:00+00:00", "published_display": "13 Aug 2026 11:30", "sentiment": "positive", "sentiment_pct": 80, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.534, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Earnings Per Share", "Financial Results", "Fourth Quarter", "Operating Income"]}], "by_tier": {"direct": [{"title": "Ascendis Pharma Reports Second Quarter 2026 Financial Results", "summary": "Ascendis Pharma \u2013 Q2 2026 product revenue of \u20ac315 million (+105% Y/Y), comprising \u20ac252 million for YORVIPATH\u00ae, \u20ac55 million for SKYTROFA\u00ae, and \u20ac8 million for YUVIWEL\u00ae \u2013 Through July 31, more than 220 unique YUVIWEL patient enrollments in the U.S. \u2013 Substantial pipeline updates: presented long-term Phase 2 & 3 YORVIPATH data, shared Week 78 COACH Trial data, and completed target enrollment for pivotal infant reACHin Trial \u2013 Settled all convertible notes and Ascendis added to multiple Russell U.S. Indexes \u2013 Conference call today at 8:00 am ET COPENHAGEN, Denmark, Aug. 13, 2026 (GLOBE NEWSWIRE) --", "url": "https://finance.yahoo.com/healthcare/articles/ascendis-pharma-reports-second-quarter-113000247.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-13T11:30:00+00:00", "published_display": "13 Aug 2026 11:30", "provider": "eodhd", "sentiment": "positive", "sentiment_pct": 80, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.534, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Earnings Per Share", "Financial Results", "Fourth Quarter", "Operating Income"]}], "industry": [], "sector": []}, "total_fetched": 1, "total_unique": 1, "total_relevant": 1, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "raw_articles": 1, "unique_stories": 1, "duplicates_removed": 0, "relevant_stories": 1, "current_evidence": 1, "direct_evidence": 1, "eodhd_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 345, "call_budget": 500, "budget_used_pct": 69.0, "requests_made": 69, "last_success_at": "2026-08-13T13:00:28.783982+00:00", "newest_seen_at": "2026-08-13T12:52:01+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 2634, "unmapped_mentions": 2004}, "status": "healthy"}, "sentiment_summary": {"positive": 1, "negative": 0, "neutral": 0, "score": 60, "raw_score": 80, "total": 1, "evidence_count": 1, "effective_articles": 1.0, "direct_story_count": 1, "industry_story_count": 0, "sector_story_count": 0, "story_count": 1, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 0, "confidence": 46, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-13T11:30:00+00:00", "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 72, "events": [{"event": "earnings", "label": "Earnings", "weight": 0.6, "count": 1}], "positive_events": 1, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 1}, "raw_articles": 1, "unique_stories": 1, "duplicates_removed": 0, "relevant_stories": 1, "current_evidence": 1, "direct_evidence": 1, "eodhd_articles": 1, "eodhd": {"configured": true, "status": "healthy", "calls_used": 345, "call_budget": 500, "budget_used_pct": 69.0, "requests_made": 69, "last_success_at": "2026-08-13T13:00:28.783982+00:00", "newest_seen_at": "2026-08-13T12:52:01+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 2634, "unmapped_mentions": 2004}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 255.41, "latest_week": "2026-08-07", "one_week_move": 4.7, "four_week_move": -5.6, "twelve_week_move": 6.2, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.356623, "market_dynamics_buy_signal": false, "relative_strength": 0.863922, "fair_value_gap": 55.3, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 53.6772, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+4.7% over one week, -5.6% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "News confirmed by price", "tone": "positive", "classification": "confirmed_positive", "summary": "Constructive news tone is being confirmed by positive weekly price action.", "confidence": 58, "badges": ["Sentiment confirms active trend", "Positive but stretched"], "opportunities": ["Constructive tone aligns with the Sharemaestro trend signal."], "risks": ["Constructive tone is arriving with price materially above fair value."], "event_label": "Earnings", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 1}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "60/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Evidence confidence", "value": "46/100", "tone": "neutral", "text": "1.0 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "News confirmed by price", "tone": "positive", "text": "Constructive news tone is being confirmed by positive weekly price action."}, {"label": "Primary event", "value": "Earnings", "tone": "positive", "text": "72/100 classification confidence."}, {"label": "Company focus", "value": "1", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "0/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "+4.7% over one week, -5.6% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Ascendis Pharma Reports Second Quarter 2026 Financial Results"}], "updated_at": "2026-08-13T13:01:53.337330+00:00", "detail_intelligence": {"headline": "News confirmed by price", "summary": "Constructive news tone is drawn from 1 fresh independent stories, including 1 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 60, "display": "60", "tone": "positive", "note": "Constructive news tone"}, {"label": "Evidence confidence", "value": 46, "display": "46", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "1 direct stories"}, {"label": "Evidence agreement", "value": 0, "display": "N/A", "tone": "neutral", "note": "requires at least 2 stories"}], "confidence_drivers": [{"label": "Sample depth", "value": 12, "note": "1.0 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 99, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 0, "note": "requires at least 2 stories"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 99, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 0, "score": null, "tone": "neutral", "x": 820.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 0, "score": null, "tone": "neutral", "x": 866.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 1, "score": 80, "tone": "positive", "x": 958.0, "y": 80.4, "volume_height": 52.0, "volume_y": 214.0}], "timeline_points": "958.0,80.4", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Establishing", "tone": "neutral", "recent_score": 80, "prior_score": null, "delta": null, "recent_count": 1, "prior_count": 0, "volume_delta": 1}, "freshness_buckets": [{"label": "Last 24 hours", "count": 1, "share": 100}, {"label": "1 to 3 days", "count": 0, "share": 0}, {"label": "4 to 7 days", "count": 0, "share": 0}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 1, "share": 100, "score": 80, "tone": "positive"}], "event_profile": [{"label": "Earnings", "count": 1, "share": 100, "score": 80, "tone": "positive"}], "topics": [{"label": "Operating Income", "count": 1, "share": 100}, {"label": "Fourth Quarter", "count": 1, "share": 100}, {"label": "Financial Results", "count": 1, "share": 100}, {"label": "Earnings Per Share", "count": 1, "share": 100}, {"label": "Earnings", "count": 1, "share": 100}, {"label": "Biotech", "count": 1, "share": 100}], "supporting": [{"label": "Direct evidence", "text": "1 current stories are mapped specifically to ASND."}, {"label": "Price response", "text": "Constructive news tone is being confirmed by positive weekly price action."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "Ascendis Pharma Reports Second Quarter 2026 Financial Results", "summary": "Ascendis Pharma \u2013 Q2 2026 product revenue of \u20ac315 million (+105% Y/Y), comprising \u20ac252 million for YORVIPATH\u00ae, \u20ac55 million for SKYTROFA\u00ae, and \u20ac8 million for YUVIWEL\u00ae \u2013 Through July 31, more than 220 unique YUVIWEL patient enrollments in the U.S. \u2013 Substantial pipeline updates: presented long-term Phase 2 & 3 YORVIPATH data, shared Week 78 COACH Trial data, and completed target enrollment for pivotal infant reACHin Trial \u2013 Settled all convertible notes and Ascendis added to multiple Russell U.S. Indexes \u2013 Conference call today at 8:00 am ET COPENHAGEN, Denmark, Aug. 13, 2026 (GLOBE NEWSWIRE) --", "url": "https://finance.yahoo.com/healthcare/articles/ascendis-pharma-reports-second-quarter-113000247.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-13T11:30:00+00:00", "published_display": "13 Aug 2026 11:30", "sentiment": "positive", "sentiment_pct": 80, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.534, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Earnings Per Share", "Financial Results", "Fourth Quarter", "Operating Income"]}, "article_count": 1, "updated_at": "2026-08-13T13:01:53.337330+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 190.6, "label": "13 Feb 2026", "close": 216.32, "index": 100.0}, {"x": 78.6, "y": 170.5, "label": "20 Feb 2026", "close": 225.0, "index": 104.0}, {"x": 115.3, "y": 150.8, "label": "27 Feb 2026", "close": 233.5, "index": 107.9}, {"x": 151.9, "y": 134.2, "label": "06 Mar 2026", "close": 240.65, "index": 111.2}, {"x": 188.6, "y": 168.2, "label": "13 Mar 2026", "close": 225.98, "index": 104.5}, {"x": 225.2, "y": 177.7, "label": "20 Mar 2026", "close": 221.88, "index": 102.6}, {"x": 261.8, "y": 189.1, "label": "27 Mar 2026", "close": 216.95, "index": 100.3}, {"x": 298.5, "y": 160.6, "label": "03 Apr 2026", "close": 229.25, "index": 106.0}, {"x": 335.1, "y": 137.4, "label": "10 Apr 2026", "close": 239.28, "index": 110.6}, {"x": 371.8, "y": 125.4, "label": "17 Apr 2026", "close": 244.48, "index": 113.0}, {"x": 408.4, "y": 160.6, "label": "24 Apr 2026", "close": 229.27, "index": 106.0}, {"x": 445.0, "y": 179.9, "label": "01 May 2026", "close": 220.93, "index": 102.1}, {"x": 481.7, "y": 138.8, "label": "08 May 2026", "close": 238.66, "index": 110.3}, {"x": 518.3, "y": 134.6, "label": "15 May 2026", "close": 240.5, "index": 111.2}, {"x": 555.0, "y": 119.4, "label": "22 May 2026", "close": 247.05, "index": 114.2}, {"x": 591.6, "y": 172.5, "label": "29 May 2026", "close": 224.11, "index": 103.6}, {"x": 628.2, "y": 204.2, "label": "05 Jun 2026", "close": 210.45, "index": 97.3}, {"x": 664.9, "y": 186.6, "label": "12 Jun 2026", "close": 218.06, "index": 100.8}, {"x": 701.5, "y": 157.0, "label": "19 Jun 2026", "close": 230.83, "index": 106.7}, {"x": 738.2, "y": 87.7, "label": "26 Jun 2026", "close": 260.75, "index": 120.5}, {"x": 774.8, "y": 55.8, "label": "03 Jul 2026", "close": 274.5, "index": 126.9}, {"x": 811.4, "y": 65.2, "label": "10 Jul 2026", "close": 270.45, "index": 125.0}, {"x": 848.1, "y": 87.1, "label": "17 Jul 2026", "close": 261.0, "index": 120.7}, {"x": 884.7, "y": 103.6, "label": "24 Jul 2026", "close": 253.86, "index": 117.4}, {"x": 921.4, "y": 126.7, "label": "31 Jul 2026", "close": 243.91, "index": 112.8}, {"x": 958.0, "y": 100.0, "label": "07 Aug 2026", "close": 255.41, "index": 118.1}], "sentiment_points": [{"x": 721.0, "y": 102.4, "label": "22 Jun 2026", "score": 65}, {"x": 721.2, "y": 102.4, "label": "22 Jun 2026", "score": 65}, {"x": 724.0, "y": 102.4, "label": "23 Jun 2026", "score": 65}, {"x": 724.4, "y": 102.4, "label": "23 Jun 2026", "score": 65}, {"x": 727.2, "y": 102.4, "label": "23 Jun 2026", "score": 65}, {"x": 727.9, "y": 104.2, "label": "24 Jun 2026", "score": 64}, {"x": 728.1, "y": 102.4, "label": "24 Jun 2026", "score": 65}, {"x": 732.1, "y": 102.4, "label": "24 Jun 2026", "score": 65}, {"x": 734.1, "y": 100.6, "label": "25 Jun 2026", "score": 66}, {"x": 735.5, "y": 102.4, "label": "25 Jun 2026", "score": 65}, {"x": 735.8, "y": 102.4, "label": "25 Jun 2026", "score": 65}, {"x": 736.1, "y": 102.4, "label": "25 Jun 2026", "score": 65}, {"x": 746.9, "y": 100.6, "label": "27 Jun 2026", "score": 66}, {"x": 747.3, "y": 100.6, "label": "27 Jun 2026", "score": 66}, {"x": 750.5, "y": 104.2, "label": "28 Jun 2026", "score": 64}, {"x": 759.2, "y": 100.6, "label": "30 Jun 2026", "score": 66}, {"x": 760.4, "y": 100.6, "label": "30 Jun 2026", "score": 66}, {"x": 761.6, "y": 100.6, "label": "30 Jun 2026", "score": 66}, {"x": 762.0, "y": 100.6, "label": "30 Jun 2026", "score": 66}, {"x": 762.1, "y": 102.4, "label": "30 Jun 2026", "score": 65}, {"x": 762.7, "y": 102.4, "label": "30 Jun 2026", "score": 65}, {"x": 762.8, "y": 102.4, "label": "30 Jun 2026", "score": 65}, {"x": 763.7, "y": 102.4, "label": "30 Jun 2026", "score": 65}, {"x": 765.7, "y": 100.6, "label": "01 Jul 2026", "score": 66}, {"x": 767.3, "y": 100.6, "label": "01 Jul 2026", "score": 66}, {"x": 769.0, "y": 102.4, "label": "01 Jul 2026", "score": 65}, {"x": 774.8, "y": 100.6, "label": "03 Jul 2026", "score": 66}, {"x": 776.8, "y": 100.6, "label": "03 Jul 2026", "score": 66}, {"x": 777.0, "y": 122.6, "label": "03 Jul 2026", "score": 54}, {"x": 778.1, "y": 100.6, "label": "03 Jul 2026", "score": 66}, {"x": 785.6, "y": 106.1, "label": "05 Jul 2026", "score": 63}, {"x": 792.6, "y": 106.1, "label": "06 Jul 2026", "score": 63}, {"x": 796.5, "y": 102.4, "label": "07 Jul 2026", "score": 65}, {"x": 803.4, "y": 98.7, "label": "08 Jul 2026", "score": 67}, {"x": 817.2, "y": 102.4, "label": "11 Jul 2026", "score": 65}, {"x": 829.2, "y": 106.1, "label": "13 Jul 2026", "score": 63}, {"x": 833.6, "y": 106.1, "label": "14 Jul 2026", "score": 63}, {"x": 836.5, "y": 106.1, "label": "14 Jul 2026", "score": 63}, {"x": 837.7, "y": 104.2, "label": "15 Jul 2026", "score": 64}, {"x": 840.1, "y": 106.1, "label": "15 Jul 2026", "score": 63}, {"x": 857.2, "y": 107.9, "label": "18 Jul 2026", "score": 62}, {"x": 881.9, "y": 109.8, "label": "23 Jul 2026", "score": 61}, {"x": 882.4, "y": 109.8, "label": "23 Jul 2026", "score": 61}, {"x": 886.2, "y": 109.8, "label": "24 Jul 2026", "score": 61}, {"x": 886.5, "y": 109.8, "label": "24 Jul 2026", "score": 61}, {"x": 893.4, "y": 111.6, "label": "25 Jul 2026", "score": 60}, {"x": 894.0, "y": 111.6, "label": "25 Jul 2026", "score": 60}, {"x": 894.1, "y": 111.6, "label": "25 Jul 2026", "score": 60}, {"x": 908.7, "y": 113.4, "label": "28 Jul 2026", "score": 59}, {"x": 929.9, "y": 115.3, "label": "01 Aug 2026", "score": 58}, {"x": 930.0, "y": 115.3, "label": "01 Aug 2026", "score": 58}, {"x": 931.6, "y": 115.3, "label": "01 Aug 2026", "score": 58}], "price_path": "42.0,190.6 78.6,170.5 115.3,150.8 151.9,134.2 188.6,168.2 225.2,177.7 261.8,189.1 298.5,160.6 335.1,137.4 371.8,125.4 408.4,160.6 445.0,179.9 481.7,138.8 518.3,134.6 555.0,119.4 591.6,172.5 628.2,204.2 664.9,186.6 701.5,157.0 738.2,87.7 774.8,55.8 811.4,65.2 848.1,87.1 884.7,103.6 921.4,126.7 958.0,100.0", "sentiment_path": "721.0,102.4 721.2,102.4 724.0,102.4 724.4,102.4 727.2,102.4 727.9,104.2 728.1,102.4 732.1,102.4 734.1,100.6 735.5,102.4 735.8,102.4 736.1,102.4 746.9,100.6 747.3,100.6 750.5,104.2 759.2,100.6 760.4,100.6 761.6,100.6 762.0,100.6 762.1,102.4 762.7,102.4 762.8,102.4 763.7,102.4 765.7,100.6 767.3,100.6 769.0,102.4 774.8,100.6 776.8,100.6 777.0,122.6 778.1,100.6 785.6,106.1 792.6,106.1 796.5,102.4 803.4,98.7 817.2,102.4 829.2,106.1 833.6,106.1 836.5,106.1 837.7,104.2 840.1,106.1 857.2,107.9 881.9,109.8 882.4,109.8 886.2,109.8 886.5,109.8 893.4,111.6 894.0,111.6 894.1,111.6 908.7,113.4 929.9,115.3 930.0,115.3 931.6,115.3", "price_change": 18.1, "sentiment_change": -7, "latest_close": 255.41, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}